Dennis Slamon, Director at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 12,211 shares at $78.33 ($957K) on 2022-02-28, disclosed to the SEC on 2022-03-02.
Open-market sale of $957k BMRN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $78.33 | 5,815 | $455K | 47.6% |
| 2 | $78.33 | 5,815 | $455K | 47.6% |
| 3 | $78.34 | 45 | $4K | 0.4% |
| 4 | $78.35 | 100 | $8K | 0.8% |
| 5 | $78.35 | 214 | $17K | 1.8% |
| 6 | $78.36 | 122 |
| $10K |
| 1.0% |
| 7 | $78.37 | 100 | $8K | 0.8% |
| Total | $78.33 avg | 12,211 | $957K | 100% |